Mental Health Clinics in Idyllwild, CA Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Cornerstone Marriage And Family Therapy Corp. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 54425 N Circle Drive, Suite 9 And 10, Idyllwild, CA 92549 Phone: 760-207-7486 |
Cornerstone Psychotherapy Group Llc Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 54240 Ridgeview Dr., Idyllwild, CA 92549 Phone: 760-207-7486 |
A Human Sanctuary Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 25168 Franklin Dr, Idyllwild, CA 92549 Phone: 808-464-9214 |
News Archive
Metal complexes could hold the key to next generation of antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.
Researchers use metagenomics to identify the cause of outbreaks of bacterial infection
Researchers have been able to reconstruct the genome sequence of an outbreak strain of Shiga-toxigenic Escherichia coli (STEC), which caused over 50 deaths in Germany, using an approach known as metagenomics which bypasses the need for growing bacteria in the lab.
Scientists develop carbon based nanoscale to detect single DNA molecules
Researchers at the University of Pennsylvania have developed a new, carbon-based nanoscale platform to electrically detect single DNA molecules.Using electric fields, the tiny DNA strands are pushed through nanoscale-sized, atomically thin pores in a graphene nanopore platform that ultimately may be important for fast electronic sequencing of the four chemical bases of DNA based on their unique electrical signature.The pores, burned into graphene membranes using electron beam technology, provide Penn physicists with electronic measurements of the translocation of DNA.
Antibe Therapeutics completes pre-clinical program for its lead product ATB-346
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") is pleased to announce that it has completed its planned pre-clinical program for its lead product ATB-346 to support initial clinical studies in humans.
› Verified 7 days ago